MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: A systematic review and meta-analysis

Oral Oncology

Volumn 51, Issue 4, 2015, Pages 321-331

  Jamali, Zahra ^a   Aminabadi, Naser Asl ^a   Attaran, Rana ^a   Pournagiazar, Fatemeh ^a   Oskouei, Sina Ghertasi ^a   Ahmadpour, Farzin ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Head and neck squamous cell carcinoma; Meta analysis; MicroRNA; miR 21; Prognosis

Indexed keywords

MICRORNA; MICRORNA 125B; MICRORNA 134A; MICRORNA 155; MICRORNA 181A; MICRORNA 18A; MICRORNA 19A; MICRORNA 21; MICRORNA 210; MICRORNA 451; UNCLASSIFIED DRUG;

CANCER PROGNOSIS; DISEASE SPECIFIC SURVIVAL; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SYSTEMATIC REVIEW; GENETICS; HEAD AND NECK TUMOR; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; MICRORNAS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84933675265     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2015.01.008     Document Type: Review

References (57)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60(5):277-300.
2. Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB. Head and neck cancer: past, present and future. Exp Rev Anticancer Ther 2006;6(7):1111-8.
3. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2003;260(9):502-8.
4. Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 2005;86(6):347-63.
5. Williams AH, Liu N, van Rooij E, Olson EN. MicroRNA control of muscle development and disease. Curr Opin Cell Biol 2009;21(3):461-9.
6. Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle 2007;6(17):2127-32.
7. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005;120(1):21-4.
8. Fu W, Pang L, Chen Y, Yang L, Zhu J, Wei Y. The MicroRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis. ScientificWorldJournal 2014;2014:523979.
9. Nair VS, Maeda LS, Ioannidis JP. Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst 2012;104(7):528-40.
10. Zhou X, Wang X, Huang Z, Wang J, Zhu W, Shu Y, et al. Prognostic value of miR-21 in various cancers: an updating meta-analysis. PLoS One 2014;9(7):e102413.
11. Li M, Ma X, Zhang B, Huang J, Liu L, Wei Y. Prognostic role of microRNA-210 in various carcinomas: a systematic review and meta-analysis. Dis Markers 2014;2014:106197.
12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Metaanalysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008-12.
13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
14. NCfBI. PubMed Help [Internet]. 2005. .
15. Fu X, Han Y, Wu Y, Zhu X, Lu X, Mao F, et al. Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur J Clin Invest 2011;41(11):1245-53.
16. Shiiba M, Shinozuka K, Saito K, Fushimi K, Kasamatsu A, Ogawara K, et al. MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma. Br J Cancer 2013;108(9):1817-21.
17. Huang WC, Chan SH, Jang TH, Chang JW, Ko YC, Yen TC, et al. MiRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Cancer Res 2014;74(3):751-64.
18. Yang CC, Hung PS, Wang PW, Liu CJ, Chu TH, Cheng HW, et al. MiR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. J Oral Pathol Med 2011;40(5):397-404.
19. Sun Q, Zhang J, Cao W, Wang X, Xu Q, Yan M, et al. Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. Int J Biochem Cell Biol 2013;45(3):513-20.
20. Harazono Y, Muramatsu T, Endo H, Uzawa N, Kawano T, Harada K, et al. MiR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS One 2013;8(5):e62757.
21. Jia LF, Wei SB, Gan YH, Guo Y, Gong K, Mitchelson K, et al. Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. Int J Cancer 2013.
22. Gao G, Gay HA, Chernock RD, Zhang TR, Luo J, Thorstad WL, et al. A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma. Cancer 2013;119(1):72-80.
23. Hedback N, Jensen DH, Specht L, Fiehn AM, Therkildsen MH, Friis-Hansen L, et al. MiR-21 expression in the tumor stroma of oral squamous cell carcinoma: an independent biomarker of disease free survival. PLoS One 2014;9(4):e95193.
24. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 2009;15(12):3998-4008.
25. Childs G, Fazzari M, Kung G, Kawachi N, Brandwein-Gensler M, McLemore M, et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009;174(3):736-45.
26. Avissar M, McClean MD, Kelsey KT, Marsit CJ. MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009;30(12):2059-63.
27. Jung HM, Phillips BL, Patel RS, Cohen DM, Jakymiw A, Kong WW, et al. Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer. J Biol Chem 2012;287(35):29261-72.
28. Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G, et al. Hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010;116(9):2148-58.
29. Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, et al. MiR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis 2013;34(2):415-25.
30. Liu CJ, Shen WG, Peng SY, Cheng HW, Kao SY, Lin SC, et al. MiR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. Int J Cancer 2014;134(4):811-21.
31. Shi LJ, Zhang CY, Zhou ZT, Ma JY, Liu Y, Bao ZX, et al. MicroRNA-155 in oral squamous cell carcinoma: overexpression, localization, and prognostic potential. Head Neck 2014.
32. Xu Q, Sun Q, Zhang J, Yu J, Chen W, Zhang Z. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis 2013;34(3):539-49.
33. Tian L, Li M, Ge J, Guo Y, Sun Y, Liu M, et al. MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. Tumour Biol 2014;35(6):5953-63.
34. Chang CC, Yang YJ, Li YJ, Chen ST, Lin BR, Wu TS, et al. MicroRNA-17/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma. Oral Oncol 2013;49(9):923-31.
35. Ogawa T, Saiki Y, Shiga K, Chen N, Fukushige S, Sunamura M, et al. MiR-34a is downregulated in cis-diamminedichloroplatinum treated sinonasal squamous cell carcinoma patients with poor prognosis. Cancer Sci 2012;103(9):1737-43.
36. Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, Yamamoto K, et al. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 2012;107(4):700-6.
37. Harris T, Jimenez L, Kawachi N, Fan JB, Chen J, Belbin T, et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am J Pathol 2012;180(3):917-28.
38. Peng SC, Liao CT, Peng CH, Cheng AJ, Chen SJ, Huang CG, et al. MicroRNAs MiR-218, MiR-125b, and Let-7g predict prognosis in patients with oral cavity squamous cell carcinoma. PLoS One 2014;9(7):e102403.
39. Barker EV, Cervigne NK, Reis PP, Goswami RS, Xu W, Weinreb I, et al. MicroRNA evaluation of unknown primary lesions in the head and neck. Mol Cancer 2009;8:127.
40. Lenarduzzi M, Hui AB, Alajez NM, Shi W, Williams J, Yue S, et al. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. PLoS One 2013;8(1):e53765.
41. Caramuta S, Egyhazi S, Rodolfo M, Witten D, Hansson J, Larsson C, et al. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. J Invest Dermatol 2010;130(8):2062-70.
42. Zeng X, Xiang J, Wu M, Xiong W, Tang H, Deng M, et al. Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS One 2012;7(10):e46367.
43. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010;16(4):1129-39.
44. Li X, Wang HL, Peng X, Zhou HF, Wang X. MiR-1297 mediates PTEN expression and contributes to cell progression in LSCC. Biochem Biophys Res Commun 2012;427(2):254-60.
45. Li T, Chen JX, Fu XP, Yang S, Zhang Z, Chen KhH, et al. MicroRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep 2011;25(5):1353-63.
46. Zhang X, Kong Y, Xu X, Xing H, Zhang Y, Han F, et al. F-box protein FBXO31 is down-regulated in gastric cancer and negatively regulated by miR-17 and miR-20a. Oncotarget 2014;5(15):6178-90.
47. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, et al. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 2006;103(24):9136-41.
48. Zhao S, Yao D, Chen J, Ding N. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer. Genet Test Mol Biomarkers 2013;17(8):631-6.
49. Chang Y, Liu C, Yang J, Liu G, Feng F, Tang J, et al. MiR-20a triggers metastasis of gallbladder carcinoma. J Hepatol 2013;59(3):518-27.
50. Zhao S, Yao DS, Chen JY, Ding N. Aberrant expression of miR-20a and miR-203 in cervical cancer. Asian Pac J Cancer Prev 2013;14(4):2289-93.
51. Shen Z, Zhan G, Ye D, Ren Y, Cheng L, Wu Z, et al. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Med Oncol 2012;29(4):2473-80.
52. Gallardo E, Navarro A, Vinolas N, Marrades RM, Diaz T, Gel B, et al. MiR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 2009;30(11):1903-9.
53. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Korner H, et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008;7(16):2591-600.
54. Avissar M, Christensen BC, Kelsey KT, Marsit CJ. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009;15(8):2850-5.
55. Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF, Yang MY. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol 2012;33(6):1933-42.
56. Wu TY, Zhang TH, Qu LM, Feng JP, Tian LL, Zhang BH, et al. MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression. Int J Clin Exp Pathol 2014;7(1):56-63.
57. Liu N, Jiang N, Guo R, Jiang W, He QM, Xu YF, et al. MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma. Mol Cancer 2013;12(1):123.